In triple-negative breast cancer, activated Akt1, but not Akt2, correlates with reduced disease recurrence-free survival53 while knock down of Akt3 significantly inhibited cell growth in spheroid culture and in mouse xenograft54. Here, AKT2 is linked to triple-negative breast carcinoma.